Neuralace Medical首席执行官Keith Warner说:“FDA对Axon Therapy的批准是PDN治疗向前迈出的重要一步。” “这种首创的非侵入性解决方案体现了我们对创新、以患者为中心的护理的承诺,能够提供有效的疼痛缓解,而没有传统、更具侵入性治疗的缺点。”
9, 2023 /PRNewswire/ -- Neuralace Medical, Inc., a commercial-stage medical technology company focused on innovative, non-invasive solutions for the treatment of chronic neuropathic pain, is announcing the commencement and ...